Estimation nationale de l'incidence et de la mortalité par cancer en France entre, 1980. ,
Estimation nationale de l'incidence des cancers en France entre, 1980. ,
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study, The Lancet Oncology, vol.15, issue.9, pp.931-973, 2014. ,
DOI : 10.1016/S1470-2045(14)70282-7
Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5), The Lancet Haematology, vol.2, issue.11, pp.481-91, 2015. ,
DOI : 10.1016/S2352-3026(15)00155-6
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995???99: results of the EUROCARE-4 study, The Lancet Oncology, vol.8, issue.9, pp.773-83, 2007. ,
DOI : 10.1016/S1470-2045(07)70245-0
URL : https://hal.archives-ouvertes.fr/hal-00492650
A Review of the Definition for Multiple Primary Cancers in the United States, Princeton, New Jersey. Springfield (IL): North American Association of Central Cancer Registries, 2002. ,
Multiple primary malignant neoplasms.I. Introduction and presentation of data, Cancer, vol.6, issue.2, pp.221-251, 1961. ,
DOI : 10.1002/1097-0142(196103/04)14:2<221::AID-CNCR2820140202>3.0.CO;2-6
Multiple primary malignant neoplasms.II. Tumors of different tissues or organs, Cancer, vol.146, issue.2, pp.231-238, 1961. ,
DOI : 10.1002/1097-0142(196103/04)14:2<231::AID-CNCR2820140203>3.0.CO;2-2
INCIDENCE AND SIGNIFICANCE OF MULTIPLE PRIMARY MALIGNANT NEOPLASMS*, Annals of the New York Academy of Sciences, vol.209, issue.2, pp.886-95, 1964. ,
DOI : 10.1111/j.1749-6632.1964.tb41011.x
Multiple Primary Malignant Neoplasms, American Journal of Clinical Oncology, vol.26, issue.1, pp.79-83, 2003. ,
DOI : 10.1097/00000421-200302000-00015
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study, Haematologica, vol.93, issue.3, pp.398-404, 2008. ,
DOI : 10.3324/haematol.12120
The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma, Cancer, vol.89, issue.1, pp.108-115, 2006. ,
DOI : 10.1002/cncr.21971
Risk of Subsequent Solid Tumors After Non-Hodgkin's Lymphoma: Effect of Diagnostic Age and Time Since Diagnosis, Journal of Clinical Oncology, vol.26, issue.11, pp.1850-1857, 2008. ,
DOI : 10.1200/JCO.2007.14.6068
Second primary cancers among 109???000 cases of non-Hodgkin's lymphoma, British Journal of Cancer, vol.69, issue.1, pp.159-166, 2005. ,
DOI : 10.1002/(SICI)1097-0215(19970917)72:6<923::AID-IJC1>3.0.CO;2-R
Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma, Leukemia & Lymphoma, vol.18, issue.82, pp.1-7, 2015. ,
DOI : 10.1054/bjoc.2001.1998
Second Cancers Among Long-term Survivors of Non-Hodgkin's Lymphoma, JNCI Journal of the National Cancer Institute, vol.85, issue.23, pp.1932-1937, 1993. ,
DOI : 10.1093/jnci/85.23.1932
Multiple Primary Malignancies - A Retrospective Analysis at a Single Center in Turkey, Asian Pacific Journal of Cancer Prevention, vol.14, issue.2, pp.769-773, 2013. ,
DOI : 10.7314/APJCP.2013.14.2.769
Synchronous and metachronous malignant tumors expect the un-expected, J Pak Med Assoc, pp.905-909, 2010. ,
Second Primary Malignant Neoplasms: A Clinicopathological Analysis from a Cancer Centre in India, Asian Pacific Journal of Cancer Prevention, vol.13, issue.12, pp.6087-6091, 2012. ,
DOI : 10.7314/APJCP.2012.13.12.6087
Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program, The Oncologist, vol.12, issue.1, pp.20-37, 2007. ,
DOI : 10.1634/theoncologist.12-1-20
Positron Emission Tomography (PET) in Oncology, Cancers, vol.6, issue.4, pp.1821-89, 2014. ,
DOI : 10.3390/cancers6041821
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group, Journal of Clinical Oncology, vol.32, issue.27, pp.3048-58, 2014. ,
DOI : 10.1200/JCO.2013.53.5229
International classification of diseases for oncology, Geneva: World Health, 2008. ,
Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnoses, European Journal of Cancer, vol.51, issue.9, pp.1109-1131, 2015. ,
DOI : 10.1016/j.ejca.2014.02.008
Epidemiologic Approaches to Multiple Primary Cancer: Critical Review from the Standpoints of Validity and Efficiency. Jpn, J Clin Oncol, vol.20, pp.1-6, 1990. ,
Statistical methods in cancer research. The design and analysis of cohort studies, IARC Sci Publ, issue.82, pp.1-406, 1987. ,
Coexistence of renal cell carcinoma and malignant lymphoma: A causal relationship or coincidental occurrence?, Cancer, vol.14, issue.11, pp.2325-2339, 1996. ,
DOI : 10.1002/(SICI)1097-0142(19960601)77:11<2325::AID-CNCR22>3.0.CO;2-Y
COINCIDENT RENAL CELL CARCINOMA AND NONHODGKIN'S LYMPHOMA: THE M.D. ANDERSON EXPERIENCE AND REVIEW OF THE LITERATURE, The Journal of Urology, vol.159, issue.3, pp.714-716, 1998. ,
DOI : 10.1016/S0022-5347(01)63708-X
An association between renal cell carcinoma and lymphoid malignancies: A case series of eight patients, Cancer, vol.11, issue.11, pp.2421-2427, 1996. ,
DOI : 10.1002/(SICI)1097-0142(19961201)78:11<2421::AID-CNCR21>3.0.CO;2-1
Renal parenchymal tumors and lymphoma in the same patient: Case series and review of the literature, American Journal of Hematology, vol.35, issue.4, pp.271-80, 2006. ,
DOI : 10.1002/ajh.20533
Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?, Annals of Oncology, vol.13, issue.2, pp.318-322, 2002. ,
DOI : 10.1093/annonc/mdf042
The effect of patient characteristics on second primary risk cancer un France, BMC Cancer, pp.14-94, 2014. ,
Rituximab efficiently depletes B cells in lung tumors??and normal lung tissue, F1000Research, vol.5, p.38, 2016. ,
DOI : 10.12688/f1000research.7599.1
Immunohistochemical markers in lymphoid malignancies: Protein correlates of molecular alterations, Seminars in Diagnostic Pathology, vol.32, issue.5, pp.381-391, 2015. ,
DOI : 10.1053/j.semdp.2015.02.016
Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011. ,
DOI : 10.1016/j.cell.2011.02.013
Multifocal Bilateral Breast Cancer and Breast Follicular Lymphoma: A Simple Coincidence?, Journal of Breast Cancer, vol.18, issue.3, pp.296-300, 2015. ,
DOI : 10.4048/jbc.2015.18.3.296
URL : http://doi.org/10.4048/jbc.2015.18.3.296
Synchronous bilateral non-Hodgkin's diffuse large B cell lymphoma of the breast and left breast invasive ductal carcinoma: a case report and review of literature, Int J Clin Exp Pathol, vol.7, pp.7042-7048, 2014. ,
Coexistent non-hodgkin's lymphoma and ductal carcinoma breast: diagnosis one fine needle aspiration cytology, Diagnostic cytopathology, pp.767-769, 2010. ,
DOI : 10.1002/dc.21547
Breast cancer incidence highest in range of one spieces of mouse, Brit J. Cancer, vol.82, pp.446-451, 2000. ,
Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells, Proceedings of the National Academy of Sciences, vol.100, issue.26, pp.15853-15858, 2003. ,
DOI : 10.1073/pnas.2136825100
Canonical Nuclear Factor ??B Pathway Links Tumorigenesis of Synchronous Mantle-Cell Lymphoma, Clear-Cell Renal-Cell Carcinoma, and GI Stromal Tumor, Journal of Clinical Oncology, vol.29, issue.10, pp.257-61, 2011. ,
DOI : 10.1200/JCO.2010.32.1802
NF-kB as a critical link between inflammation and cancer, Cold Spring Harb Perspect Biol, pp.11-14, 2009. ,
DOI : 10.1101/cshperspect.a000141
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773649
B cell-regulated immune responses in tumor models and cancer patients, OncoImmunology, vol.11, issue.7, pp.7-25443, 2013. ,
DOI : 10.1002/cncr.26204
Tumor-infiltrating B cells, OncoImmunology, vol.1, issue.7, pp.1186-1188 ,
DOI : 10.1016/j.coi.2008.03.003
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494640
Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer, Cancer Research, vol.71, issue.17, pp.5678-5687, 2011. ,
DOI : 10.1158/0008-5472.CAN-11-0431
Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery, Cancer Immunology, Immunotherapy, vol.9, issue.2, pp.171-180, 2016. ,
DOI : 10.1007/s00262-015-1787-0
Tertiary lymphoid strutures, drivers of the anti-tumor responses in human cancers, Immunological Reviews, pp.260-275, 2016. ,
Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers, Cancers, vol.6, issue.2, pp.969-997, 2014. ,
DOI : 10.3390/cancers6020969
Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of immature immunophenotype and produce functional IgG, Plos One, vol.7, 2012. ,
Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?, Cancer Immunology, Immunotherapy, vol.1, issue.1, pp.643-662, 2014. ,
DOI : 10.1007/s00262-014-1544-9